Brown & Brown stock holds below target as Q2 2026 growth lags peers
Published on 09/01/2026 at 08:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Brown & Brown, Inc. (US1156371007) stock is trading in the low $70s as of late August 2026, reflecting a mixed picture in the company’s latest quarterly results and sector comparisons in the insurance brokerage space.
Per recent reporting dated August 31, 2026, Brown & Brown opened at $73.32 on the New York Stock Exchange and closed at $73.31 on the last completed trading session, placing the shares modestly below the current consensus price target in the mid-$70 range for the stock.
At the same time, the latest sector analysis highlights that Brown & Brown delivered strong top-line expansion in the second quarter of 2026, with reported revenue of $1.65 billion, yet its organic growth rate for the period came in slightly negative, contrasting with several public peers that achieved mid-single-digit positive organic growth.
Q2 2026 results show strong revenue but softer organic growth
Brown & Brown’s most recent reported quarter is the second quarter of 2026, and the company’s financials show a clear mix of strengths and challenges for investors evaluating the stock.
According to a detailed earnings summary for Q2 2026, Brown & Brown generated revenue of $1.65 billion for the quarter ended in 2026, an increase of 30.4% compared with the same quarter a year earlier, highlighting robust expansion in reported sales over a 12-month period. The same source notes that the firm’s net margin stood at 17.75% for the quarter, with return on equity of 13.17%, underlining a relatively profitable profile despite some earnings pressure.
On the earnings per share line, Brown & Brown reported Q2 2026 EPS of $1.07, which was $0.01 below the consensus estimate of $1.08 for the quarter. While the shortfall versus expectations was small in absolute dollar terms, it still represents a slight miss relative to analyst forecasts that had anticipated a marginally higher bottom-line contribution from the insurance broker.
The same earnings overview indicates that Brown & Brown’s quarterly revenue was up 30.4% year over year, while EPS in the comparable prior-year quarter was $1.03, meaning that current-quarter EPS increased by $0.04 over the past year. This combination of double-digit revenue growth and mid-single-digit EPS growth suggests that margin expansion has been more modest than the top-line increase, a factor that can influence how investors value the shares.
The company’s reported net margin of 17.75% in Q2 2026, alongside a return on equity of 13.17%, points to solid profitability for an insurance brokerage and risk advisory firm, but those figures must be weighed against the softer organic growth rate in assessing the broader performance trend.
Organic growth contrasts with sector peers in Q2 2026
Beyond headline revenue and EPS, Brown & Brown’s second quarter of 2026 is notable for its organic growth profile, which provides a lens on the underlying expansion of its existing operations excluding certain acquisitions and currency effects.
Recent sector commentary on public insurance brokers states that Brown & Brown delivered organic growth of negative 0.7% in Q2 2026, meaning that its underlying revenue base declined slightly in that period when adjusted for inorganic contributions. This negative 0.7% organic growth figure stands out because comparative references to several peers in the same sector show that those companies posted organic growth in the range of 5% to 6% in Q2 2026, a gap of more than 5 percentage points between Brown & Brown and the peer group.
The same sector analysis explains that Brown & Brown’s negative organic growth suggests its revenue base felt the impact of softer renewal rate increases and fewer large new accounts in the quarter, especially when set against peers that were still able to record mid-single-digit positive organic growth despite similar market conditions.
For investors, the contrast between Brown & Brown’s negative 0.7% organic growth and the 5% to 6% organic growth at several competitors in Q2 2026 is a key quantified comparison: it implies that Brown & Brown underperformed the sector’s organic expansion by roughly 6 percentage points, even though its reported total revenue still rose 30.4% year over year due to acquisitions and other non-organic factors.
This differential can contribute to a more cautious stance among some market participants, who might value the stock less aggressively if they view organic growth as a more reliable indicator of sustainable performance than reported revenue growth that is heavily influenced by transactional activity.
Analyst view and consensus expectations
Despite the slight earnings miss and weaker organic growth, Brown & Brown remains a widely covered name among equity analysts, with several recent data points helping to frame the current consensus view as of late August 2026.
A recent stock-performance and valuation summary indicates that Brown & Brown shares opened at $73.32 in the latest trading session, with analysts collectively expecting full-year earnings per share of 4.5 for the current fiscal year. That full-year EPS expectation, when compared with the latest quarterly EPS of $1.07, implies that the market anticipates continued earnings contribution in the remaining quarters of the year and builds a picture of the company’s annual profitability profile.
The same summary notes that Brown & Brown pays a quarterly dividend of $0.165 per share, corresponding to an annualized dividend of $0.66 and a dividend yield of 0.9% based on the prevailing share price levels in late August 2026. For income-focused investors, that 0.9% yield is modest when set against higher-yielding financial stocks, but it does offer a small cash return alongside potential capital appreciation.
On the rating side, the current data show that the analyst community holds a consensus rating of Hold on Brown & Brown, with a consensus price target of $76.80 for the shares. When compared with the recent closing price of $73.31, that average target implies potential upside of $3.49 per share or approximately 4.8% if the stock were to move to the consensus valuation level in line with analyst expectations.
Additionally, one recent rating action saw Brown & Brown receive a Sell recommendation from a major bank, according to an August 31, 2026 note that cited the shares closing at $73.31 in the last session and highlighted the gap between current price and the existing price target consensus of $74.62. While the bank’s Sell rating is more negative than the broader Hold consensus, the associated price target still sits slightly above the current share price, indicating that the call is more focused on relative valuation and risk-reward trade-offs than on a prediction of severe downside.
As of late August 2026, institutional ownership in Brown & Brown stands at 71.01% of outstanding shares, based on recent filings and aggregated holdings data. This high level of institutional participation underscores the stock’s position as a substantial component of professional portfolios in the insurance and financial services space, which can contribute to trading liquidity and ongoing analyst attention.
Market reaction and share price context
Against the backdrop of Q2 2026 results and the organic growth discussion, Brown & Brown’s share price behavior in the latest sessions provides additional context for retail investors tracking the stock.
Recent quote data show that the stock opened at $73.32 on the NYSE and closed at $73.31 in the most recent completed trading session, reflecting an extremely small intraday change of $0.01 and signaling a relatively steady price over that day’s trading range. This price level sits modestly below both the broader consensus price target of $76.80 and the more specific target of $74.62 cited in a recent bank rating note, placing the shares within a few dollars of the levels that analysts currently consider fair value.
The fact that Brown & Brown’s stock price is trading under the consensus target but not deeply discounted suggests that recent earnings and organic growth developments have tempered enthusiasm without triggering a pronounced sell-off. The moderate gap of about 4.8% between the recent closing price of $73.31 and the $76.80 consensus price target signals limited expected upside from current levels under the prevailing analyst models.
Sector commentary also mentions a forthcoming corporate action for Brown & Brown in the form of a board-approved 2-for-1 stock split dated August 5, 2026, with new shares scheduled to be distributed on September 2, 2026. In practical terms, this split means that each existing share of Brown & Brown will be divided into two shares, effectively halving the quoted share price while doubling the number of shares held by each shareholder without changing the underlying economic interest.
Because the split distribution occurs on September 2, 2026, the stock’s quoted price in the low $70s as of the last completed pre-split trading session will convert into a price in the mid-$30s on a split-adjusted basis once the action is completed, all else being equal. For investors reviewing charts and historical prices, it will be important to distinguish between pre-split and post-split quotations when evaluating performance and valuation ratios.
Dividend, cash returns, and capital structure
Brown & Brown’s capital return strategy centers on a modest but consistent cash dividend, supplemented by its overall profitability and earnings trajectory, which together contribute to shareholder returns.
Recent dividend information indicates that the firm declared a quarterly dividend of $0.165 per share, which was paid on August 19, 2026 to investors of record as of August 12, 2026. On an annualized basis, that quarterly payout equates to a total dividend of $0.66 per share, generating a yield of 0.9% when calculated against the share price near $73.31 at the time of the dividend announcement and payment.
From a capital structure perspective, the company’s ability to sustain a dividend while also increasing revenue by 30.4% year over year in Q2 2026 and delivering EPS growth from $1.03 to $1.07 suggests that Brown & Brown is maintaining adequate profitability and cash flow to support both expansion and shareholder distributions. However, given the relatively low yield, the dividend appears positioned more as a stability signal than as a primary driver of total return.
The presence of a board-approved 2-for-1 stock split also interacts with capital return perceptions, as splits can sometimes be interpreted as a sign of management confidence in the company’s long-term prospects. After the split, the $0.165 per-share dividend would need to be evaluated in the context of potential adjustments to the payout per share on a split-adjusted basis, though the company’s overall dividend policy is typically designed to reflect sustainable earnings and cash generation.
Brown & Brown’s insurance brokerage offering
Brown & Brown, Inc. operates as a professional insurance brokerage and risk advisory firm that provides a wide range of property and casualty, employee benefits, personal risk, and specialty insurance products and services to clients across multiple sectors.
Within this portfolio, a representative offering is its commercial property and casualty insurance brokerage service, which helps corporate customers secure coverage for risks such as physical asset damage, liability exposures, and business interruption. The firm works with various insurance carriers to assemble tailored coverage packages based on the specific risk profiles and operational needs of its clients.
In the commercial property and casualty segment, Brown & Brown leverages its advisory capabilities to evaluate client exposures, negotiate terms, and manage claims, positioning itself as an intermediary that can translate complex risk factors into practical insurance solutions. The company’s expertise in this area is a core part of its value proposition and underpins much of the fee income that contributes to the revenue figures highlighted in its Q2 2026 financials.
As insurance pricing cycles evolve and clients reassess coverage requirements, Brown & Brown’s ability to maintain or grow organic revenue in this product area will be closely tied to its success in retaining existing accounts, winning new business, and navigating changes in premium rates across the broader market.
Stock split and price reference for retail investors
For retail investors considering Brown & Brown stock as of early September 2026, the interaction between the company’s financial performance, analyst views, and the forthcoming stock split is central to understanding the near-term trading context.
The most recent pre-split quote data indicate that Brown & Brown shares closed at $73.31 in the last completed trading session ahead of the split distribution, with consensus price targets of $76.80 and $74.62 suggesting modest expected upside relative to the current price level. Once the 2-for-1 stock split is executed on September 2, 2026, these price references will be adjusted on a split basis, and the stock will trade at approximately half the pre-split dollar level while maintaining the same market capitalization.
Investors should therefore interpret any post-split price movement in the context of the company’s Q2 2026 revenue growth of 30.4%, EPS of $1.07 versus prior-year $1.03, and organic growth of negative 0.7% relative to peer organic growth rates of 5% to 6% in the same period. Together, these figures frame a narrative in which Brown & Brown delivers strong reported expansion and solid profitability but faces challenges in driving organic growth at the pace of its sector peers.
As the stock transitions through the corporate action and into subsequent trading sessions, future earnings releases and updated analyst models will likely focus on whether Brown & Brown can close the gap between its organic growth trajectory and that of other publicly traded insurance brokers, and whether its earnings profile continues to support valuations in the current consensus range.
Fact box: Brown & Brown key data
Company: Brown & Brown, Inc.
ISIN: US1156371007
Ticker: BRO
Exchange: NYSE
Price (as of August 31, 2026, 4:00 p.m. ET): $73.31 USD
Market cap: Not specified in the latest available sources
Sector / Industry: Financials / Insurance brokerage and risk advisory
Index membership: Not specified in the latest available sources
